Option Care Health, Inc.
OPCH
Rank in Stocks
#3623
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Share Price
$31.28
Market Cap
$4.68B
Change (1 day)
0.21%
Change (1 year)
10.20%
Country
US
Trade Option Care Health, Inc. (OPCH)
Category
Healthcare
Revenue for Option Care Health, Inc. (OPCH)
Revenue in Jun 2026 TTM: $5.69B
According to Option Care Health, Inc. latest financial reports the company's current revenue (TTM) is $5.69B. In 2023 the company made a revenue of $4.30B an increase over the revenue in the year 2022 that was $3.94B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Option Care Health, Inc. from 2000 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $5.69B | 13.91% |
| 2024 | $5.00B | 16.17% |
| 2023 | $4.30B | 9.06% |
| 2022 | $3.94B | 14.72% |
| 2021 | $3.44B | 13.39% |
| 2020 | $3.03B | 31.26% |
| 2019 | $2.31B | 19.11% |
| 2018 | $1.94B | 137.37% |
| 2017 | $817.19M | -12.66% |
| 2016 | $935.59M | -4.75% |
| 2015 | $982.22M | 6.46% |
| 2014 | $922.65M | 32.48% |
| 2013 | $696.47M | 17.36% |
| 2012 | $593.45M | 7.02% |
| 2011 | $554.51M | 28.74% |
| 2010 | $430.71M | -67.60% |
| 2009 | $1.33B | -5.16% |
| 2008 | $1.40B | 17.05% |
| 2007 | $1.20B | 3.98% |
| 2006 | $1.15B | 7.37% |
| 2005 | $1.07B | 70.16% |
| 2004 | $630.52M | 7.09% |
| 2003 | $588.77M | 2.11% |
| 2002 | $576.60M | 26.27% |
| 2001 | $456.65M | 35.03% |
| 2000 | $338.17M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $78.01B | 1,270.21% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 283.10% |
US
|
|
| $3.89B | -31.59% |
SA
|
|
| $11.08B | 94.69% |
BR
|
